Clinical Trial

Oxygen Therapy in Diabetic Kidney Disease

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Diabetic kidney disease (DKD) is the most significant cause of end-stage kidney disease (ESKD). Albuminuria, evolving from microalbuminuria to nephrotic-range proteinuria, is a clinical hallmark of diabetic nephropathy (DN). It develops in about a third of diabetic patients and is considered an independent risk factor in the progression of DN and for all-cause mortality.
Trial Details
NCT Number NCT06959485
Lead Sponsor Assiut University
Conditions Diabetic Kidney Disease
Enrollment 80 participants
Start Date 2025-08-01
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-10 (estimated)
Updated on ClinicalTrials.gov 2025-05-06